These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 19916846)

  • 1. The importance of toxoplasma gondii infection in diseases presenting with headaches. Headaches and aseptic meningitis may be manifestations of the Jarisch-Herxheimer reaction.
    Prandota J
    Int J Neurosci; 2009; 119(12):2144-82. PubMed ID: 19916846
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Recurrent headache as the main symptom of acquired cerebral toxoplasmosis in nonhuman immunodeficiency virus-infected subjects with no lymphadenopathy: the parasite may be responsible for the neurogenic inflammation postulated as a cause of different types of headaches.
    Prandota J
    Am J Ther; 2007; 14(1):63-105. PubMed ID: 17303977
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Migraine associated with patent foramen ovale may be caused by reactivation of cerebral toxoplasmosis triggered by arterial blood oxygen desaturation.
    Prandota J
    Int J Neurosci; 2010 Feb; 120(2):81-7. PubMed ID: 20199198
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Toxoplasma gondii: a potential role in the genesis of psychiatric disorders].
    Fond G; Capdevielle D; Macgregor A; Attal J; Larue A; Brittner M; Ducasse D; Boulenger JP
    Encephale; 2013 Feb; 39(1):38-43. PubMed ID: 23095600
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Neuropsychiatric disease and Toxoplasma gondii infection.
    Henriquez SA; Brett R; Alexander J; Pratt J; Roberts CW
    Neuroimmunomodulation; 2009; 16(2):122-33. PubMed ID: 19212132
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inhibition of inducible nitric oxide synthase exacerbates chronic cerebral toxoplasmosis in Toxoplasma gondii-susceptible C57BL/6 mice but does not reactivate the latent disease in T. gondii-resistant BALB/c mice.
    Schlüter D; Deckert-Schlüter M; Lorenz E; Meyer T; Röllinghoff M; Bogdan C
    J Immunol; 1999 Mar; 162(6):3512-8. PubMed ID: 10092808
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Recognition and management of toxoplasmosis.
    Heitman BB; Irizarry AF
    Nurse Pract; 1997 Sep; 22(9):75, 79-82, 85-6 passim. PubMed ID: 9314166
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immunoregulation by Toxoplasma gondii infection prevents allergic immune responses in mice.
    Wagner A; Förster-Waldl E; Garner-Spitzer E; Schabussova I; Kundi M; Pollak A; Scheiner O; Joachim A; Wiedermann U
    Int J Parasitol; 2009 Mar; 39(4):465-72. PubMed ID: 18938169
    [TBL] [Abstract][Full Text] [Related]  

  • 9. IL-10 is not required to prevent immune hyperactivity during memory responses to Toxoplasma gondii.
    Wille U; Nishi M; Lieberman L; Wilson EH; Roos DS; Hunter CA
    Parasite Immunol; 2004 May; 26(5):229-36. PubMed ID: 15491472
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Toxoplasma gondii serology in HIV-infected patients: the development of central nervous system toxoplasmosis in AIDS.
    Grant IH; Gold JW; Rosenblum M; Niedzwiecki D; Armstrong D
    AIDS; 1990 Jun; 4(6):519-21. PubMed ID: 2386617
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Laboratory diagnosis of Toxoplasma gondii infection and toxoplasmosis.
    Montoya JG
    J Infect Dis; 2002 Feb; 185 Suppl 1():S73-82. PubMed ID: 11865443
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Detection of the initial site of Toxoplasma gondii reactivation in brain tissue.
    Takashima Y; Suzuki K; Xuan X; Nishikawa Y; Unno A; Kitoh K
    Int J Parasitol; 2008 Apr; 38(5):601-7. PubMed ID: 18022177
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Toxoplasma gondii infection in marrow transplant recipients: a 20 year experience.
    Slavin MA; Meyers JD; Remington JS; Hackman RC
    Bone Marrow Transplant; 1994 May; 13(5):549-57. PubMed ID: 8054907
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Problems and limitations of conventional and innovative methods for the diagnosis of Toxoplasmosis in humans and animals].
    Piergili Fioretti D
    Parassitologia; 2004 Jun; 46(1-2):177-81. PubMed ID: 15305712
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Involvement of apoptosis and interferon-gamma in murine toxoplasmosis.
    Shen DF; Matteson DM; Tuaillon N; Suedekum BK; Buggage RR; Chan CC
    Invest Ophthalmol Vis Sci; 2001 Aug; 42(9):2031-6. PubMed ID: 11481268
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluation of immunization with tachyzoite excreted-secreted proteins in a novel susceptible mouse model (A/Sn) for Toxoplasma gondii.
    Costa-Silva TA; Meira CS; Ferreira IM; Hiramoto RM; Pereira-Chioccola VL
    Exp Parasitol; 2008 Nov; 120(3):227-34. PubMed ID: 18706414
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Host cholesterol and inflammation as common key regulators of toxoplasmosis and artherosclerosis development.
    Portugal LR; Fernandes LR; Alvarez-Leite JI
    Expert Rev Anti Infect Ther; 2009 Sep; 7(7):807-19. PubMed ID: 19735223
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Serum and aqueous humour cytokine response and histopathological alterations during ocular Toxoplasma gondii infection in C57BL/6 mice.
    Calabrese KS; Tedesco RC; Zaverucha do Valle T; Barbosa HS
    Micron; 2008 Dec; 39(8):1335-41. PubMed ID: 18343675
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Simultaneous depletion of CD4+ and CD8+ T lymphocytes is required to reactivate chronic infection with Toxoplasma gondii.
    Gazzinelli R; Xu Y; Hieny S; Cheever A; Sher A
    J Immunol; 1992 Jul; 149(1):175-80. PubMed ID: 1351500
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Infection with Toxoplasma gondii reduces established and developing Th2 responses induced by Nippostrongylus brasiliensis infection.
    Liesenfeld O; Dunay IR; Erb KJ
    Infect Immun; 2004 Jul; 72(7):3812-22. PubMed ID: 15213122
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.